converting an API to a salt, but many APIs are not compatible with this type of chemical transformation. [13] Therefore, formulation nanotechnologies are a more general and powerful approach to improve the solubility and absorption, distribution, meta bolism, and excretion properties of hydrophobic APIs toward improving clinical performance. In contrast, current nanomedicines have primarily focused on targeted delivery (e.g., cellular uptake) of oncology drugs, [14] albeit with slow and expensive development. [15] Solubility enhancement requires a sensitive balance of API solid state stability and the solubility in aqueous solution. Approaches such as lipid-based systems (such as self-emulsifying drug delivery systems), [16,17] cyclodextrin complexation, [18] and nanovehicles (micelles, liposomes, or dendrimers) [19] improve solubility by introducing a more hydrophobic interface onto which the API partitions in equilibrium with the aqueous solution. However, these co-solutes can hinder API-target binding if partitioning is too effective and also yield low API loading and toxicity concerns due to significant excipient content. [20] Methods such as nanocrystal formation, [4,[21][22][23] amorphous polymer nanoparticles, [24] and porous nanoparticles [5,25] improve the solubility and dissolution rate by stabilizing the API in a state with high surface energy (that depends on API particle size, crystallinity, and polymorph). [26,27] Of the available formulation nanotechnologies, nanocrystal formation has been the most successful for hydrophobic APIs and is used in several food and drug administrationapproved products. [4,21,22] By retaining the crystalline structure, nanocrystals are more stable than amorphous API and are relatively stable to polymorph transformations. [28] Nanocrystals can be synthesized with sizes as small as 100 nm with minimal stabilizer material to limit toxicity and increase drug loading. [4,22,[29][30][31] The large curvature and surface area of nanocrystals provide a driving force for higher solubility (Ostwald-Freundlich equation) and correspondingly faster dissolution (Noyes-Whitney equation) relative to particles on the micrometer scale or larger. [32] In the case of orally delivered nanocrystals, absorption and thus bioavailability are directly correlated with solubility and dissolution rate. [4] An improved dissolution rate also contributes Formulation technologies are critical for increasing the efficacy of drug products containing poorly soluble hydrophobic drugs, which compose roughly 70% of small molecules in commercial pipelines. Nanomedicines, such as nanocrystal formulations and amorphous solid suspensions, are effective approaches to increasing solubility. However, existing techniques require additional processing into a final dosage form, which strongly influences drug delivery and clinical performance. To enhance hydrophobic drug product efficacy and clinical throughput, a hydrogel material is developed as a sacrificial template to simultaneously form and encapsulate nanocrystal...